RIFAMATE RIFAMATE (Rifamate 150 mg / 300 mg)
Generic Name: isoniazid/rifampin
Pill imprint RIFAMATE RIFAMATE has been identified as Rifamate 150 mg / 300 mg.
Rifamate is used in the treatment of tuberculosis, active and belongs to the drug class antituberculosis combinations. FDA has not classified the drug for risk during pregnancy. Rifamate 150 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- RIFAMATE RIFAMATE
- 150 mg / 300 mg
- 14.00 mm
- Prescription only
- Drug Class:
- Antituberculosis combinations
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Aventis Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
FD&C Blue No. 1
FD&C Red No. 40
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|68258-9014||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about Rifamate (isoniazid / rifampin)
- Other brands: IsonaRif
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.